Sarcopenic obesity diagnosis by different criteria mid-to long-term post-bariatric surgery
- PMID: 35947895
- DOI: 10.1016/j.clnu.2022.07.006
Sarcopenic obesity diagnosis by different criteria mid-to long-term post-bariatric surgery
Abstract
Background/aims: The aim of this study was to apply the European Society for Clinical Nutrition and Metabolism/European Association for the Study of Obesity (ESPEN/EASO) consensus to identify sarcopenic obesity (SO) in adults mid to long-term post-Roux-en-Y gastric bypass (RYGB) using both dual-energy x-ray absorptiometry (DXA) and bioelectrical impedance analysis (BIA). Further, this approach was compared to accepted sarcopenia diagnostic criteria (Revised European Working Group on Sarcopenia in Older People [EWGSOP2] and Sarcopenia Definition and Outcomes Consortium [SDOC]).
Methods: This cross-sectional study included adults ≥2 years post-RYGB surgery. Obesity was diagnosed by excess fat mass (FM) for all diagnostic criteria. Agreement was evaluated using Cohen's Kappa.
Results: We evaluated 186 participants (90.9% female, median age 43.9 years, 6.8 years post-surgery), of which 60.2% (BIA), and 83.3% (DXA) had excess FM. Low muscle strength was not identified using absolute handgrip strength. The prevalence of SO by BIA or DXA, respectively, was 7.9% (95%CI 3.9-12.5), and 23.0% (95%CI 17.1-30.3) [ESPEN/EASO SO consensus]; 0.7% (95%CI 0-2.0), and 3.3% (95%CI 0.7-5.9) [EWGSOP2]; and 27.0% (95%CI 19.7-34.2), and 30.3% (95%CI 23.0-37.5) [SDOC]. Agreement between the ESPEN/EASO SO consensus and other diagnostic criteria was none to slight using DXA: EWGSOP2 k = 0.19; 95% CI 0.04-0.34, or SDOC k = 0.16; 95% CI -0.01-0.32. Moderate agreement was observed within the ESPEN/EASO SO consensus for BIA and DXA (k = 0.43; 95% CI 0.26-0.60).
Conclusions: This is the first study to explore the prevalence of SO using the ESPEN/EASO criteria. We identified a high but variable prevalence of SO in post-bariatric surgery patients (7.9-23.0%), depending on the body composition technique used; prevalence was higher using DXA. Little agreement was observed for the diagnosis of SO using the three diagnostic criteria. Future studies are needed to explore the relationship between SO identified by the ESPEN/EASO consensus and health status/outcomes.
Keywords: Bariatric surgery; Body composition; Obesity; Physical function; Sarcopenia; Sarcopenic obesity.
Copyright © 2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Conflict of interest statement
Conflict of interest CMP reports receiving honoraria and/or paid consultancy from Abbott Nutrition, Nutricia, Nestle Health Science, Fresenius Kabi, and Pfizer, and grant funding from Almased.
Similar articles
-
Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions.Clin Nutr. 2023 Sep;42(9):1610-1618. doi: 10.1016/j.clnu.2023.07.014. Epub 2023 Jul 17. Clin Nutr. 2023. PMID: 37481869
-
Prevalence of sarcopenic obesity according to different diagnostic methods and cut-off points in candidates for bariatric surgery.Clin Nutr. 2024 May;43(5):1087-1093. doi: 10.1016/j.clnu.2024.03.015. Epub 2024 Apr 1. Clin Nutr. 2024. PMID: 38579371
-
The diagnostic agreement of sarcopenic obesity with different definitions in Chinese community-dwelling middle-aged and older adults.Front Public Health. 2024 Jun 6;12:1356878. doi: 10.3389/fpubh.2024.1356878. eCollection 2024. Front Public Health. 2024. PMID: 38903580 Free PMC article.
-
Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review.Clin Nutr. 2020 Aug;39(8):2368-2388. doi: 10.1016/j.clnu.2019.11.024. Epub 2019 Nov 27. Clin Nutr. 2020. PMID: 31813698
-
The Asia-Oceania consensus: Definitions and diagnostic criteria for sarcopenic obesity.Obes Res Clin Pract. 2025 May-Jun;19(3):185-192. doi: 10.1016/j.orcp.2025.05.001. Epub 2025 May 6. Obes Res Clin Pract. 2025. PMID: 40335420
Cited by
-
Poor muscle quality: A hidden and detrimental health condition in obesity.Rev Endocr Metab Disord. 2025 Jan 21. doi: 10.1007/s11154-025-09941-0. Online ahead of print. Rev Endocr Metab Disord. 2025. PMID: 39833502 Review.
-
Sarcopenic obesity: a review.Arch Endocrinol Metab. 2025 Apr 11;68:e240084. doi: 10.20945/2359-4292-2024-0084. Arch Endocrinol Metab. 2025. PMID: 40215288 Free PMC article. Review.
-
Sarcopenia Prevalence among Hospitalized Patients with Severe Obesity: An Observational Study.J Clin Med. 2024 May 13;13(10):2880. doi: 10.3390/jcm13102880. J Clin Med. 2024. PMID: 38792422 Free PMC article.
-
Analysis of sarcopenic obesity prevalence and diagnostic agreement according to the 2022 ESPEN and EASO Consensus in hospitalized older adults with severe obesity.Front Endocrinol (Lausanne). 2024 Jun 20;15:1366229. doi: 10.3389/fendo.2024.1366229. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38966224 Free PMC article.
-
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence.Rev Endocr Metab Disord. 2024 Aug;25(4):677-689. doi: 10.1007/s11154-023-09864-8. Epub 2024 Mar 1. Rev Endocr Metab Disord. 2024. PMID: 38427134 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials